Moving Past Theranos: What Is Possible With Blood Analysis?
Once valued at over $9 billion dollars, it seemed like Theranos was going to change the world of routine blood testing.
United States Piccolo Xpress Jamesh Nichols Kimberly Sanford Sheldon Campbell American Society Of Clinical Pathology
Source: medscape.com